Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine
Publication/Creation DateOctober 31 2021
Description"Cybin, a Toronto-based psychedelic therapeutics startup, is sponsoring the study. The study will begin before the end of the year with 15 patients at a ketamine-assisted therapy clinic in Marina Del Rey, California. All patients will go through two rounds of the trial. The first one will be a placebo session with saline solution so the Kernel Flow brain-imaging device can get a baseline for the patient’s neurological activity and the second session patients will get an intramuscular injection of a psychedelic dose of ketamine while wearing the Kernel Flow headset."
Date archivedNovember 25 2021
Last editedNovember 25 2021